Skip to main content
Galvanta Pharma
  • Company
  • Services
  • Manufacturing
  • Quality
  • Portfolio
  • Business
  • Regulatory
  • Safety
  • Contact
Khmer
MenuClose menu
  • Company
  • Services
  • Manufacturing
  • Quality
  • Portfolio
  • Business
  • Regulatory
  • Safety
  • Contact

Product records and publication rules

This policy governs medicine-related records published on galvanta.com by GALVANTA COMPANY LIMITED. It applies to page text, titles, descriptions, images, linked documents and other representations of a record.

Effective: 23 September 2026. Last reviewed: 23 September 2026.
On this pageCurrent statusMeaning of a product recordSeparate evidence requirementsPublic communicationContent limitsDocumentary enquiriesCorrections and status changesChanges to this policy

Current status

The company holds no pharmaceutical manufacturing licence, GMP certificate, product registration or marketing authorisation.

A medicine authorised for another organisation or country does not establish authorisation for the company or for the presentation shown here.

Meaning of a product record

A product record identifies a substance or supplied substance name, strength, form or presentation, and pack. It is not an approved product label, prescribing document, patient leaflet or specification for supply.

Where a record lists more than one strength or presentation, each combination requires its own evidence.

A device description, such as a pen or cartridge, does not by itself identify the pharmaceutical formulation. Total container contents must not be interpreted as a dose.

Separate evidence requirements

Product identity, manufacturing permission, GMP certification, product registration and advertising permission are separate matters.

Authority-issued records control statements about regulatory status. A company list, packaging image, proposed commercial arrangement or application reference does not establish approval.

No pharmacopoeial compliance, manufacturer role or marketing-authorisation-holder role is established by a product name or image.

Public communication

A public product record can fall within pharmaceutical advertising rules even when it contains no price or ordering facility.

Cambodian pharmaceutical law requires Ministry of Health authorisation for pharmaceutical advertising. Commercial-advertising rules cover digital communications. The applicable rules depend on the substance, activity, audience, channel and jurisdiction.

The lawfulness of a communication route requires separate assessment of its audience, access arrangements and any private enquiry.

Content limits

Public identity records contain no indications, dosing instructions, efficacy or safety claims, comparative claims, prices, stock statements or commitments to supply.

Product images are not evidence of registration, approved labelling, released batches or authenticity. Images and identity fields must not be used for prescribing, dispensing, importing or authenticating a medicine.

Suitability for an individual requires a separate clinical assessment, including where an identity record contains no particular warning.

Documentary enquiries

Requests may be sent to [email protected]. Identify the exact record, jurisdiction, requesting organisation and document required.

A request does not establish that the document exists, can be released or supports a proposed activity. Disclosure depends on the information held, the requester’s purpose, applicable law and any relevant confidentiality restriction.

Do not send patient records or confidential formulations in an initial enquiry.

Corrections and status changes

Unsupported or outdated content may be corrected, restricted or withdrawn. Any change to a regulatory statement requires evidence for the exact entity, product, activity and jurisdiction concerned.

Publication rules also apply to search descriptions and images. A new approval requires authority evidence separate from a website date change.

Send record corrections to the public email address, identifying the page and the specific issue. See Content and regulatory communications, Medical information and Regulatory information.

Changes to this policy

Revisions apply from the stated effective date. This policy cannot authorise publication or an activity prohibited by applicable law.

Galvanta Pharma

GALVANTA COMPANY LIMITED

A Cambodian company in the pharmaceutical sector, established in Cambodia.

Company registration number 1000634930.

The company holds no pharmaceutical manufacturing licence, GMP certificate, product registration or marketing authorisation.

Official Facebook page

Company information

  • Company
  • Manufacturing
  • Quality
  • Regulatory information
  • Services
  • Product records
  • Business enquiries
  • Contact

Reporting

  • Adverse events
  • Product-quality concerns and recalls
  • Suspected falsification
  • Business conduct
  • Website security

Contact

[email protected]

Registered office

Shop No. 2F-60, Sihanoukville Special Economic Zone
Preah Sihanouk Province, Cambodia

Website policies

  • Legal notice and policies

© 2026 GALVANTA COMPANY LIMITED. Rights reserved to the extent provided by law.

LegalTermsPrivacyCookiesSitemap
English|Khmer